New York Law Journal | Analysis
By Francis J. Serbaroli | May 16, 2022
In his Health Law column, Francis J. Serbaroli discusses additional liabilities that lawyers should be aware of when settling Medicare or Medicaid fraud cases for their clients. He explains some of the additional weapons that the federal and state governments can deploy against clients after a settlement is finalized.
By Jane Wester | May 4, 2022
"The reality is that politics is the only salvation," Kolbert said. "Our opponents knew that." Kolbert, who argued in the landmark Planned Parenthood v. Casey case before the U.S. Supreme Court, urged attorneys to think beyond litigation as they plan their responses to the expected decision in Dobbs.
By Brian Lee | May 2, 2022
The legal battle stems from the state's decision in 2011 to reduce its premium contributions under an optional health-benefit plan for active and retired state employees.
By Jane Wester | April 22, 2022
The three-judge panel said a Department of Health & Human Services rule aligned with plaintiffs' argument over who should pay for medications, but it did not apply retroactively, thus denying her relief.
By Jane Wester | April 20, 2022
Attorneys representing the medical professionals named as policyholders on the insurance policies argued that the money should go to their clients.
By Amanda Bronstad | April 19, 2022
A growing list of consumer products are now being targeted in lawsuits for containing PFAS, or polyfluoroalkyl substances, also known as "forever chemicals."
New York Law Journal | Analysis
By Shari Claire Lewis | April 18, 2022
Although the Health Breach Notification Rule has long been available to the FTC, the FTC has not actively enforced it. However, the FTC now appears to be poised to changing its approach. It has signaled renewed interest in the Rule, largely in recognition of the evolution of technology and health care since the Rule's passage that has caused an explosive expansion of the amount of health data collected by organizations and entities that are not otherwise governed by HIPAA and its progeny.
New York Law Journal | Analysis
By Jason Rimland and Charles Goodwin | April 11, 2022
There has been an explosion of renewed interest in the psychedelic space, specifically in the medical application of psychedelic substances as a therapeutic treatment for mental and emotional disorder. This has caught the eye of some of the largest names in private equity, and investor enthusiasm is not going unnoticed.
By Amanda Bronstad | April 7, 2022
Matt Leckman, a partner at Littlepage Booth Leckman, represents the wife of a pilot allegedly sickened from toxic cabin air, which is caused when engine fumes seep into the cabin. Trial begins on April 18 in Chicago.
By Tom McParland | April 5, 2022
In a nine-page summary order, the Second Circuit affirmed the ruling of a lower court judge, who last year described an anti-abortion activist's cause of action as "in a word, ridiculous."
The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
Job Opportunity: Location: Prestigious Florida Law Firm seeks to hire a Business attorney with at least 5 years of experience for their Ft. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS